A long noncoding RNA associated with susceptibility to celiac disease

Area of Science:

• Molecular Biology
• Genetics
• Immunology

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators of diverse biological processes.
• Celiac disease involves chronic inflammation of the small intestine, triggered by gluten in genetically susceptible individuals.

Purpose of the Study:

• To identify and characterize a novel lncRNA, termed lnc13, associated with celiac disease.
• To elucidate the regulatory mechanism of lnc13 in controlling inflammatory gene expression.
• To investigate the role of lnc13 dysfunction in the pathogenesis of celiac disease.

Main Methods:

• Identification and characterization of the lnc13 lncRNA.
• Analysis of lnc13's interaction with heterogeneous nuclear ribonucleoprotein D (hnRNPD).
• Quantification of lnc13 expression in small intestinal biopsy samples from celiac disease patients and healthy controls.
• Assessment of the binding efficiency of a celiac disease-associated lnc13 variant to hnRNPD.

Main Results:

• Lnc13 was identified as a lncRNA harboring a celiac disease-associated haplotype.
• Lnc13 represses the expression of specific inflammatory genes under homeostatic conditions by binding to hnRNPD.
• Lnc13 levels decrease upon stimulation, leading to increased expression of repressed genes.
• Lnc13 expression is significantly reduced in small intestinal biopsies from celiac disease patients.
• A celiac disease-associated variant of lnc13 exhibits reduced binding affinity to hnRNPD compared to the wild-type.

Conclusions:

• Down-regulation of lnc13 may contribute to the inflammatory processes observed in celiac disease.
• Impaired interaction between the disease-associated lnc13 variant and hnRNPD provides a molecular mechanism for the contribution of single-nucleotide polymorphisms to celiac disease pathogenesis.
• Lnc13 represents a potential therapeutic target for managing celiac disease-related inflammation.